UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES AND EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 12, 1999
Commission file number 1-12055
PARACELSUS HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
CALIFORNIA 95-3565943
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
515 W. Greens Road, Suite 800, Houston, Texas
(Address of principal executive offices)
77067 (281) 774-5100
(Zip Code) (Registrant's telephone number,
including area code)
<PAGE>2
ITEM 5. OTHER EVENTS
In a letter dated January 29, 1999, the New York Stock Exchange ("NYSE")
notified Paracelsus Healthcare Corporation ("the Company") that it would
remain listed on the NYSE. The NYSE's determination is contingent on the
Company's undertaking to update the NYSE quarterly to demonstrate progress
in returning to compliance with the NYSE's listing standards.
Certain statements in this release are "forward-looking statements" made
pursuant to the safe harbor provisions for the Private Securities
Litigation Reform Act of 1995. Forward-looking statements involve a number
of risks and uncertainties. Additionally, there are many factors, including
but not limited to, a change in the Company's NYSE listing status and the
price of the Company's stock, which may cause the Company's actual
performance to differ materially from forecasted results. Given these
uncertainties, prospective investors are cautioned not to place undue
reliance on such forward-looking statements.
<PAGE>3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Paracelsus Healthcare Corporation
(Registrant)
Dated: February 12, 1999 By: /S/ JAMES G. VANDEVENDER
----------------------------------
James G. VanDevender
Senior Executive Vice President,
Chief Financial Officer
& Director
